You are here: Industry Insights > small molecule drugs

News List

Breakthrough in Research of Small Molecule Drugs against SARS-CoV-2 PharmaSources/Xiaonisha
March 21, 2022
Corona virus disease 2019 (COVID-19) caused by a novel single-stranded RNA coronavirus has swept the world. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-2.
Roche, Jnana sign multi-target collaboration deal for small molecule drugs pharmaceutical-business-review
July 24, 2020
Jnana Therapeutics has signed a multi-target collaboration and license deal worth over $1bn with Roche for the discovery of small molecule drugs for the treatment of immune-mediated and neurological diseases.
Biologics or small molecule drugs for rare disease treatment? It is a question PharmaSources/Miling
July 31, 2019
To both patients and pharmaceutical practitioners, it is a question as to whether to choose biologics or small molecule drugs for rare disease treatment, since the prices are sky-high.
Skyhawk and Takeda partner to develop small molecule drugs pharmaceutical-technology
May 08, 2019
US-based Skyhawk Therapeutics has formed a strategic alliance with Takeda Pharmaceutical to discover and develop small molecule drug candidates for multiple targets across neurodegenerative diseases.
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D b3cnewswire
July 18, 2017
RedHill Biopharma Ltd. announced that the last patient enrolled in the Phase II study with BEKINDA® (RHB-102)(1) 12 mg for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) has completed the treatment course and follow-up visit.